Literature DB >> 25578228

Comparing the prognostic performance of ASSIST to interleukin-6 and procalcitonin in patients with severe sepsis or septic shock.

Hector R Wong1, Keith R Walley, Ville Pettilä, Nuala J Meyer, James A Russell, Sari Karlsson, Michael G S Shashaty, Christopher J Lindsell.   

Abstract

CONTEXT: We recently derived and validated a multi-biomarker-based model (ASSIST) to stratify patients with sepsis based on initial mortality risk.
OBJECTIVE: The objective of this study was to compare the performance of ASSIST to interleukin-6 (IL6) and procalcitonin (PCT).
METHODS: The area-under-the-receiver operating characteristic curve for predicting 28-d mortality using ASSIST was compared with that of IL6 (n = 452) and PCT (n = 235).
RESULTS: The area under the curve for ASSIST was greater than that of IL6 and PCT.
CONCLUSIONS: ASSIST estimated the probability of mortality more reliably than IL6 and PCT in this cohort of patients with sepsis.

Entities:  

Keywords:  Biomarkers; decision tree; modeling; outcome; sepsis; stratification

Mesh:

Substances:

Year:  2015        PMID: 25578228     DOI: 10.3109/1354750X.2014.1000971

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  6 in total

Review 1.  Emerging infection and sepsis biomarkers: will they change current therapies?

Authors:  Lauren Jacobs; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2016-08-17       Impact factor: 5.091

2.  Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults.

Authors:  Daniel Molano Franco; Ingrid Arevalo-Rodriguez; Marta Roqué I Figuls; Nadia G Montero Oleas; Xavier Nuvials; Javier Zamora
Journal:  Cochrane Database Syst Rev       Date:  2019-04-30

3.  Sepsis without SIRS is still sepsis.

Authors:  Bryan G Yipp; Brent W Winston
Journal:  Ann Transl Med       Date:  2015-11

4.  An Enrichment Strategy For Sepsis Clinical Trials.

Authors:  Hector R Wong; Christopher J Lindsell
Journal:  Shock       Date:  2016-12       Impact factor: 3.454

5.  A prospective observational cohort study to identify inflammatory biomarkers for the diagnosis and prognosis of patients with sepsis.

Authors:  Valentino D'Onofrio; Dries Heylen; Murih Pusparum; Inge Grondman; Johan Vanwalleghem; Agnes Meersman; Reinoud Cartuyvels; Peter Messiaen; Leo A B Joosten; Mihai G Netea; Dirk Valkenborg; Gökhan Ertaylan; Inge C Gyssens
Journal:  J Intensive Care       Date:  2022-03-09

Review 6.  Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure.

Authors:  Alexandre Mebazaa; Pierre François Laterre; James A Russell; Andreas Bergmann; Luciano Gattinoni; Etienne Gayat; Michael O Harhay; Oliver Hartmann; Frauke Hein; Anne Louise Kjolbye; Matthieu Legrand; Roger J Lewis; John C Marshall; Gernot Marx; Peter Radermacher; Mathias Schroedter; Paul Scigalla; Wendy Gattis Stough; Joachim Struck; Greet Van den Berghe; Mehmet Birhan Yilmaz; Derek C Angus
Journal:  J Intensive Care       Date:  2016-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.